Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência.
Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Treatment with brensocatib significantly and safely extended the time to a first exacerbation and lowered flare rates in people with non-cystic fibrosis bronchiectasis (NCFBE), results from a Phase 2 trial show. ... Read more
People with asthma who also have bronchiectasis are at greater risk of severe disease and exacerbations, and more likely to be admitted to the hospital, compared with patients without bronchiectasis, ... Read more
Children diagnosed with non-cystic fibrosis bronchiectasis since 2002 have better lung function at diagnosis, distinct disease causes, and higher frequency of sputum infections, compared to children followed in the same ... Read more
Transplanting progenitor cells to the lungs of bronchiectasis patients is safe and appears to stabilize disease, with no worsening in lung and physical function for at least 48 weeks, findings ... Read more
Savara Pharmaceuticals has acquired global rights to develop and commercialize Grifols‘ inhaled antibiotic formulation Apulmiq (ciprofloxacin) for the treatment for non-cystic fibrosis bronchiectasis (NCFB). The agreement comes a couple of ... Read more
The nonprofit NTM Info & Research (NTMir) has launched a companion website that provides extensive insight into bronchiectasis and related infections, empowering people with the condition to participate in their ... Read more
Bronchiectasis Severity Index (BSI) and FACED are prediction tools that can provide clinically relevant evaluations of bronchiectasis severity, mortality and several other outcomes that may influence clinical decision-making processes and ... Read more
Patients with non-cystic fibrosis bronchiectasis have better outcomes when they have particular mutations in both copies of the FUT2 gene, according to researchers at the South Australian Health and Medical ... Read more
Obese bronchiectasis patients with gastroesophageal reflux disease (GERD) may benefit from antireflux proton pump inhibitors according to researchers at the Seoul National University Bundang Hospital, in Korea. The study “Effect of Proton ... Read more
Male gender, a history of tuberculosis, and high levels of serum total immunoglobulin E (T-IgE) are all risk factors for bronchiectasis in COPD patients, researchers at Beijing Tongren Hospital and at ... Read more